logo
Select company
Select metric
$ 20.8MWorking Capital
VS
Market
40
Sector
36
Industry
36
History
3
$ 10.3Close
$ 5.97 - $ 67 52-Week Range
Ticker Information

Ticker

MRSN

Company Name

MERSANA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MERSANA THERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRSN - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 80.14M$ 59.34M$ 20.8M
3/31/2025$ 106.19M$ 58.16M$ 48.03M
12/31/2024$ 136.9M$ 62.46M$ 74.45M
9/30/2024$ 160.56M$ 68.3M$ 92.26M
6/30/2024$ 168.96M$ 62.18M$ 106.78M
3/31/2024$ 187.54M$ 53.41M$ 134.13M
12/31/2023$ 214.06M$ 63.64M$ 150.42M
9/30/2023$ 249.74M$ 67.93M$ 181.81M
6/30/2023$ 297.09M$ 74.92M$ 222.17M
3/31/2023$ 281.81M$ 83.4M$ 198.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 253.86M.
  • Over the past 5 years, MERSANA THERAPEUTICS INC's average Working Capital has been $ 159.4M.
  • The median Working Capital for MERSANA THERAPEUTICS INC during this period was $ 173.71M
  • MERSANA THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 253.86M.
  • The lowest Working Capital recorded by MERSANA THERAPEUTICS INC in the same timeframe $ 20.8M

MERSANA THERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
XFOR : X4 PHARMACEUTICALS INC $ 50.05MGBIO : GENERATION BIO CO $ 126.13MXLO : XILIO THERAPEUTICS INC $ 70.46MSNYR : SYNERGY CHC CORP $ 12.38MCCEL : CRYO CELL INTERNATIONAL INC $ -8.7MICCC : IMMUCELL CORP $ 12.69MCAMP : CAMP4 THERAPEUTICS CORP $ 33.75MIGC : IGC PHARMA INC $ 428KDYAI : DYADIC INTERNATIONAL INC $ 3.75MRVP : RETRACTABLE TECHNOLOGIES INC $ 54.01M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for MERSANA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 274.93M ] - LiabilitesC [ $ 21.07M ]
(=) Working Capital [ $ 253.86M ]

MRSN - Working Capital, Last 5 years

$ 20.8M

Minimum

Jun 30, 2025

$ 253.86M

Maximum

Sep 30, 2020

$ 159.4M

Average

$ 173.71M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -465.2M
max$ 607.04M
average$ 96.5M
median$ 32.21M
std$ 173.86M